Home > Boards > US Listed > Biotechs > Assertio Therapeutics, INC (ASRT)

News: $ASRT Assertio Therapeutics Announces Favorable NUCYNTA® Patent Ruling

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
 
Followed By 45
Posts 5,811
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2019 5:16:42 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/1/2019 5:13:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/30/2019 5:01:53 PM
Assertio Therapeutics Announces Appointment of Dr. David Wheadon to its Board of Directors GlobeNewswire Inc. - 9/30/2019 12:35:20 PM
Assertio Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/20/2019 6:36:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/20/2019 4:14:41 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 8/20/2019 4:12:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/20/2019 4:08:45 PM
Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference GlobeNewswire Inc. - 8/20/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/15/2019 5:53:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2019 4:36:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2019 7:46:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2019 6:43:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2019 6:43:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2019 4:09:24 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/9/2019 4:02:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/9/2019 10:30:52 AM
Assertio Therapeutics Announces Exchange Offer of $200 Million of its Currently Outstanding 2.50% Convertible Notes Due 2021 GlobeNewswire Inc. - 8/9/2019 9:28:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2019 4:05:01 PM
Assertio Therapeutics Announces Strong Second-Quarter 2019 Results GlobeNewswire Inc. - 8/7/2019 4:02:00 PM
Assertio Therapeutics to Report Second Quarter 2019 Financial Results After The Close of Markets on Wednesday, August 7, 201... GlobeNewswire Inc. - 7/17/2019 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/14/2019 5:21:43 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/10/2019 1:30:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/9/2019 6:28:42 PM
whytestocks   Thursday, 03/28/19 02:00:39 PM
Re: None
Post # of 21 
News: $ASRT Assertio Therapeutics Announces Favorable NUCYNTA® Patent Ruling

LAKE FOREST, Ill., March 28, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that the United States Court of Appeals for the Federal Circuit has ruled in favor of Assertio with respect to the company’s patent litigation against three filers of Abbr...

Got this from https://marketwirenews.com/news-releases/assertio-therapeutics-announces-favorable-nucynta-xae-patent-ruling-7908312.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist